VeriMom¿Es tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate seguro durante el embarazo?
No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
Pregnancy-safe products containing tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate
Related ingredients
Frequently asked questions
- ¿Es tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate seguro durante el embarazo?
- No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
- ¿Es tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate seguro durante la lactancia?
- No data located showing lactational transfer, mammary toxicity, or reproductive system effects. No SCCS/CIR opinion or harmonised hazard for this ingredient. Therefore default hazard/mechanism = 0 and exposure from topical cosmetic use is considered negligible based on peptide structure and marketed aqueous/glycerin formulations. Sources: DSM Syn‑HYCAN product literature, EPA CompTox, PubMed search (no relevant studies found).
- ¿Es tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate seguro para la piel del bebé?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- ¿Cómo puntúa VeriMom a tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate?
- VeriMom puntúa tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate en el embarazo?
- Consulta nuestra lista de alternativas seguras a tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.